European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478- ^hot^ -

This guide is for informational purposes only. Always refer to the official current edition of the European Pharmacopoeia for legally binding requirements.

: Single or multi-layer tablets without specific release-modifying excipients.

The monograph specifies the test methods that must be used to evaluate tablets, including:

The defining characteristic is that the tablet must be homogeneous (dose uniformity) and stable (mechanical resistance to handling).

The "Tablets -0478-" monograph is essential for manufacturers, regulators, and control laboratories involved in the development, production, and quality control of tablets. The monograph provides a comprehensive framework for evaluating the quality of tablets and ensures that medicinal products available to patients in Europe meet the required standards. European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-

: Tablets covered with one or more layers of mixtures of various substances (such as resins, gelatin, or sugars) or film-coated variants.

Ensure volume consistency and structural cohesion.

The monograph outlines several "mandatory" tests that tablets must pass to be compliant. These include: Uniformity of Dosage Units

Control active substance release behavior throughout the digestive tract. Key Quality Control and Physical Testing Requirements This guide is for informational purposes only

| Average mass (mg) | Percentage deviation | |-------------------|----------------------| | ≤ 80 | 10% | | 81 – 250 | 7.5% | | > 250 | 5% |

Monograph 0478 distinguishes several specific categories, each with tailored requirements:

| Average Mass of Tablet | Percentage Deviation | | :--- | :--- | | 80 mg or less | 10% | | More than 80 mg to 250 mg | 7.5% | | More than 250 mg | 5% |

Master Ph. Eur. 0478, and you master tablet quality control. Overlook its nuance, and you risk the entire European market. The monograph specifies the test methods that must

Understanding is essential for pharmaceutical manufacturers, formulation scientists, and quality control (QC) analysts seeking compliance across European markets. Core Definition and Scope

While it primarily covers standard oral tablets, the monograph explicitly segmentizes several distinct categories of tablets, each with tailored criteria:

: Typically used for tablets containing high doses of API where the active substance makes up most of the tablet bulk.